The trouble with Ostarine: Jimmy Wallhead’s
16th March 2018
USADA announced today that an arbitrator from the American Arbitration Association North American Court of Arbitration for Sport (AAA) has rendered a decision in the case of swimmer Sam Tierney, of Columbia, Missouri, and has determined that Tierney should receive a public warning for his rule violation. Tierney, 23, declared the use of an inhaler containing the prohibited substance Vilanterol Trifenatate, during an in-competition test on June, 3, 2016.
Tierney was using the inhaler under the care of a medical professional, but did not check to see if his medication was prohibited, and did not apply for a TUE prior to taking it. The results of that in-competition test were negative. Vilanterol Trifenatate is a Beta-2 Agonist, prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the rules of the Fédération Internationale de Natation (FINA), both of which have adopted the World Anti-Doping Code (“Code”) and the World Anti-Doping Agency (“WADA”) Prohibited List. Beta-2 agonists are listed as Specified Substances, and therefore can result in a reduced sanction.
• This media release was originally published by the US Anti-Doping Agency (USADA) on 24 June 2016. To access the original, please click here.
USADA announced today that James Ellis, of Phoenix, Ariz., an athlete in the sport of...
Ever since a global anti-doping movement formed with the arrival of the World Anti-Doping Agency...